• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease.增强子和长非编码 RNA 调控的表观遗传机制在心血管疾病中的作用。
Curr Opin Cardiol. 2020 May;35(3):234-241. doi: 10.1097/HCO.0000000000000728.
2
Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.长链非编码 RNA 在心血管疾病中的病理基础及临床应用。
Hypertension. 2021 Jul;78(1):16-29. doi: 10.1161/HYPERTENSIONAHA.120.16752. Epub 2021 Jun 1.
3
Epigenetic mechanisms underlying the benefits of flavonoids in cardiovascular health and diseases: are long non-coding RNAs rising stars?黄酮类化合物对心血管健康和疾病有益的潜在表观遗传机制:长链非编码RNA会成为后起之秀吗?
Crit Rev Food Sci Nutr. 2022;62(14):3855-3872. doi: 10.1080/10408398.2020.1870926. Epub 2021 Jan 11.
4
The role of long noncoding RNAs in the epigenetic control of gene expression.长链非编码RNA在基因表达表观遗传调控中的作用。
ChemMedChem. 2014 Mar;9(3):505-10. doi: 10.1002/cmdc.201300569. Epub 2014 Feb 2.
5
LncRNAs: the good, the bad, and the unknown.长链非编码 RNA:有好有坏,还有未知。
Biochem Cell Biol. 2024 Feb 1;102(1):9-27. doi: 10.1139/bcb-2023-0155. Epub 2023 Aug 14.
6
The biological function and potential mechanism of long non-coding RNAs in cardiovascular disease.长链非编码 RNA 在心血管疾病中的生物学功能及潜在机制。
J Cell Mol Med. 2020 Nov;24(22):12900-12909. doi: 10.1111/jcmm.15968. Epub 2020 Oct 13.
7
Super-enhancer lncs to cardiovascular development and disease.超级增强子长链非编码RNA与心血管发育及疾病
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1953-60. doi: 10.1016/j.bbamcr.2015.11.026. Epub 2015 Nov 24.
8
Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.心血管疾病患者中临床表观遗传学的紧急扩展。
Curr Opin Cardiol. 2021 May 1;36(3):295-300. doi: 10.1097/HCO.0000000000000843.
9
ncRNAs and polyphenols: new therapeutic strategies for hypertension.ncRNAs 和多酚:高血压的新治疗策略。
RNA Biol. 2022;19(1):575-587. doi: 10.1080/15476286.2022.2066335. Epub 2021 Dec 31.
10
Epigenetic regulation by long noncoding RNAs in plants.长非编码 RNA 在植物中的表观遗传调控。
Chromosome Res. 2013 Dec;21(6-7):685-93. doi: 10.1007/s10577-013-9392-6.

引用本文的文献

1
Palmitic acid alters enhancers/super-enhancers near inflammatory and efferocytosis-associated genes in human monocytes.棕榈酸会改变人类单核细胞中炎症和胞葬作用相关基因附近的增强子/超级增强子。
J Lipid Res. 2025 Apr;66(4):100774. doi: 10.1016/j.jlr.2025.100774. Epub 2025 Mar 9.
2
Genetics and epigenetics of diabetes and its complications in India.印度糖尿病及其并发症的遗传学和表观遗传学。
Hum Genet. 2024 Jan;143(1):1-17. doi: 10.1007/s00439-023-02616-3. Epub 2023 Nov 24.
3
Cannabinoid enhancement of lncRNA MMP25-AS1/MMP25 interaction reduces neutrophil infiltration and intestinal epithelial injury in HIV/SIV infection.大麻素增强 lncRNA MMP25-AS1/MMP25 相互作用,减少 HIV/SIV 感染中的中性粒细胞浸润和肠道上皮损伤。
JCI Insight. 2023 Apr 10;8(7):e167903. doi: 10.1172/jci.insight.167903.
4
Epigenetic Mechanisms Involved in Inflammaging-Associated Hypertension.炎症相关高血压的表观遗传机制。
Curr Hypertens Rep. 2022 Nov;24(11):547-562. doi: 10.1007/s11906-022-01214-4. Epub 2022 Jul 7.
5
Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes.血清FGD5-AS1的诊断意义及其对2型糖尿病患者心血管疾病发生的预测价值。
Diabetol Metab Syndr. 2022 Jan 28;14(1):20. doi: 10.1186/s13098-022-00789-x.
6
Emerging Role of Long Non-Coding RNAs in Diabetic Vascular Complications.长链非编码 RNA 在糖尿病血管并发症中的新兴作用。
Front Endocrinol (Lausanne). 2021 Jun 21;12:665811. doi: 10.3389/fendo.2021.665811. eCollection 2021.
7
Knockdown of lncRNA ENST00000609755.1 Confers Protection Against Early oxLDL-Induced Coronary Heart Disease.长链非编码RNA ENST00000609755.1的敲低赋予对早期氧化型低密度脂蛋白诱导的冠心病的保护作用。
Front Cardiovasc Med. 2021 May 21;8:650212. doi: 10.3389/fcvm.2021.650212. eCollection 2021.
8
lncRNA DRAIR is downregulated in diabetic monocytes and modulates the inflammatory phenotype via epigenetic mechanisms.长链非编码 RNA DRAIR 在糖尿病单核细胞中表达下调,并通过表观遗传机制调节炎症表型。
JCI Insight. 2021 Jun 8;6(11):143289. doi: 10.1172/jci.insight.143289.
9
Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia.在患有高血压、糖尿病和血脂异常的成年人中确定心血管疾病的易感基因座。
J Transl Med. 2021 Feb 25;19(1):85. doi: 10.1186/s12967-021-02751-3.
10
Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture.糖尿病血管并发症和代谢记忆中的表观遗传机制:2020 年 Edwin Bierman 奖演讲。
Diabetes. 2021 Feb;70(2):328-337. doi: 10.2337/dbi20-0030.

本文引用的文献

1
Regulation of gene expression by cis-acting long non-coding RNAs.顺式作用长非编码 RNA 对基因表达的调控。
Nat Rev Genet. 2020 Feb;21(2):102-117. doi: 10.1038/s41576-019-0184-5. Epub 2019 Nov 15.
2
Differential chamber-specific expression and regulation of long non-coding RNAs during cardiac development.在心脏发育过程中长链非编码 RNA 的差异腔室特异性表达和调控。
Biochim Biophys Acta Gene Regul Mech. 2019 Oct;1862(10):194435. doi: 10.1016/j.bbagrm.2019.194435. Epub 2019 Nov 1.
3
The long noncoding RNA CHROME regulates cholesterol homeostasis in primate.长链非编码 RNA CHROME 调节灵长类动物的胆固醇稳态。
Nat Metab. 2019 Jan;1(1):98-110. doi: 10.1038/s42255-018-0004-9. Epub 2018 Dec 3.
4
The diverse roles of DNA methylation in mammalian development and disease.DNA 甲基化在哺乳动物发育和疾病中的多种作用。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):590-607. doi: 10.1038/s41580-019-0159-6. Epub 2019 Aug 9.
5
CRISPR Tools for Systematic Studies of RNA Regulation.CRISPR 工具在 RNA 调控系统研究中的应用
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):a035386. doi: 10.1101/cshperspect.a035386.
6
Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis.平滑肌细胞表型调节的抗动脉粥样硬化作用及单细胞分析揭示的 TCF21 疾病基因。
Nat Med. 2019 Aug;25(8):1280-1289. doi: 10.1038/s41591-019-0512-5. Epub 2019 Jul 29.
7
Regulation of expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA.邻近的反义转录长非编码 RNA 对人血管内皮细胞 表达的调控。
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16410-16419. doi: 10.1073/pnas.1904108116. Epub 2019 Jul 26.
8
The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling.人类特异性平滑肌细胞丰富的长非编码 RNA SMILR 通过调节有丝分裂中心体相关蛋白 CENPF mRNA 促进增殖,并驱动细胞周期进程,这一过程可以作为限制血管重构的靶点。
Circ Res. 2019 Aug 16;125(5):535-551. doi: 10.1161/CIRCRESAHA.119.314876. Epub 2019 Jul 24.
9
Endothelial function and dysfunction in the cardiovascular system: the long non-coding road.心血管系统中的内皮功能和功能障碍:长非编码 RNA 的作用。
Cardiovasc Res. 2019 Oct 1;115(12):1692-1704. doi: 10.1093/cvr/cvz154.
10
Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.循环非编码 RNA 与蛋白生物标志物在心肌损伤检测中的比较分析。
Circ Res. 2019 Jul 19;125(3):328-340. doi: 10.1161/CIRCRESAHA.119.314937. Epub 2019 Jun 4.

增强子和长非编码 RNA 调控的表观遗传机制在心血管疾病中的作用。

Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease.

机构信息

Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte, California, USA.

出版信息

Curr Opin Cardiol. 2020 May;35(3):234-241. doi: 10.1097/HCO.0000000000000728.

DOI:10.1097/HCO.0000000000000728
PMID:32205477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7526644/
Abstract

PURPOSE OF REVIEW

Hyperlipidemia, hypertension, diabetes and related metabolic disorders increase the risk for cardiovascular disease (CVD). Despite significant progress in the identification of key mechanisms and genetic polymorphisms linked to various CVDs, the rates of CVDs continue to escalate, underscoring the need to evaluate additional mechanisms for more effective therapies. Environment and lifestyle changes can alter epigenetic mechanisms mediated by histone modifications and long noncoding RNAs (lncRNAs) which play important roles in gene regulation. The review summarizes recent findings on the role of epigenetic mechanisms in CVD.

RECENT FINDINGS

Recent studies identified dysregulated histone modifications and chromatin modifying proteins at cis-regulatory elements, including enhancers/super-enhancers, mediating the expression of genes associated with CVD in vascular and immune cells in response to growth factors and inflammatory mediators. Several lncRNAs have also been reported to contribute to pathological gene expression via cis and trans mechanisms involving interactions with nuclear proteins, co-operation with enhancers/super enhancers and acting as microRNA sponges.

SUMMARY

Epigenomic approaches in cells affected in CVDs can be exploited to understand the function of genetic polymorphisms at cis-regulatory elements and crosstalk between enhancers and lncRNAs associated with disease susceptibility and progression. The reversible nature of epigenetics provides opportunities for the development of novel therapeutic strategies for CVD.

摘要

目的综述

高脂血症、高血压、糖尿病和相关代谢紊乱会增加心血管疾病(CVD)的风险。尽管在确定与各种 CVD 相关的关键机制和遗传多态性方面取得了重大进展,但 CVD 的发病率仍在不断上升,这表明需要评估其他机制以实现更有效的治疗。环境和生活方式的改变可以改变组蛋白修饰和长链非编码 RNA(lncRNA)介导的表观遗传机制,这些机制在基因调控中发挥着重要作用。本文综述了表观遗传机制在 CVD 中的作用的最新研究发现。

最新发现

最近的研究发现,血管和免疫细胞中的顺式调控元件(包括增强子/超级增强子)中的组蛋白修饰和染色质修饰蛋白失调,这些元件介导与 CVD 相关的基因表达,这些基因对生长因子和炎症介质有反应。据报道,一些 lncRNA 还通过涉及与核蛋白相互作用、与增强子/超级增强子合作以及作为 microRNA 海绵的顺式和反式机制,导致病理性基因表达。

总结

可以利用 CVD 相关细胞中的表观基因组方法来了解顺式调控元件中遗传多态性的功能以及与疾病易感性和进展相关的增强子和 lncRNA 之间的串扰。表观遗传的可逆性为 CVD 的新型治疗策略的发展提供了机会。